Novartis AG (NVSEF) stock
NVSEFOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as NVS
$146.46+2.56 (+1.78%)
Close on Oct 19, 2026Market cap $279.46BP/E 20.5Yield –
Novartis pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Novartis's pe ratio was 22.3× on Nov 3, 2026, against 22.2× a year earlier. Over the last 5 years it ranged from 7.2× to 33.1×, with a median of 20.7×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 3, 2026 | 22.3× | −1.2 |
| 2025 | Dec 31, 2025 | 23.5× | +9.8 |
| 2024 | Dec 31, 2024 | 13.7× | −18.1 |
| 2023 | Dec 29, 2023 | 31.9× | +23.3 |
| 2022 | Dec 30, 2022 | 8.5× | −16.3 |
| 2021 | Dec 31, 2021 | 24.8× | +6.2 |
| 2020 | Dec 31, 2020 | 18.7× | +1.1 |
| 2019 | Dec 31, 2019 | 17.6× | −8.8 |
| 2018 | Dec 31, 2018 | 26.4× | −3.6 |
| 2017 | Dec 29, 2017 | 30.0× | +20.0 |
| 2016 | Dec 30, 2016 | 10.0× | – |
See a number that looks wrong?